Ann-Marie E Bröske

DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction

Ann-Marie E Bröske, Lena Vockentanz, Shabnam Kharazi et al. · Nature Genetics · 2009 · 464 citations

Life Sciences, Hematology, Molecular Biology +16

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Martin Hutchings, Franck Morschhauser, Gloria Iacoboni et al. · Journal of Clinical Oncology · 2021 · 413 citations · Full text

Life Sciences, Immunology, Oncology +17

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

Philippe A. Cassier, Antoîne Italiano, Carlos Gomez-Roca et al. · The Lancet Oncology · 2015 · 363 citations

Medicine, Oncology, Pharmacology +14

Mesenchymal Stromal Cell Characteristics Vary Depending on Their Origin

Heike Wegmeyer, Ann-Marie E Bröske, Mathias Leddin et al. · Stem Cells and Development · 2013 · 219 citations

Life Sciences, Cell Biology, Immunology +13

Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

Norbert Vey, Jacques Delaunay, Giovanni Martinelli et al. · Oncotarget · 2016 · 99 citations · Full text

Medicine, Hematology, Oncology +15